Printed From BioPortfolio.com
Financial Analysis: SCYNEXIS
15:16 EDT 1 Oct 2017 | Topix
SCYNEXIS and Impax Laboratories are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. 36.8% of SCYNEXIS shares are owned by institutional investors.
Original Article: Financial Analysis: SCYNEXIS
